PatientMatch — Privacy-first clinical trial discovery

77 trials

Sickle Cell DiseaseRecruiting now

Enrolling now24

Nationwide

A Phase 1b Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

Disc Medicine, Inc

Ph 1·~2yr·3 sites in AL, IN, NY

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A Phase I/II Study of ITU512

Novartis Pharmaceuticals

Ph 1/2·~5yr·1 site in FL

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Novo Nordisk A/S

Ph 3·~4yr·49 sites in AL, AR, AZ +24

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

SPARKLE Trial: Crizanlizumab vs. Placebo for Frequent Vaso-Occlusive Crises in Sickle Cell Disease

Novartis Pharmaceuticals

Ph 3·~5yr·13 sites in AL, DC, FL +8

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

Allo HSCT for High Risk Hemoglobinopathies

Masonic Cancer Center, University of Minnesota

Ph 2·~8yr·1 site in MN

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

AlloSCT for Blood Disorders

Mitchell Cairo

Ph 2·~7yr·1 site in NY

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Arginine Therapy for Pain in Children with Sickle Cell Disease

Emory University

Ph 1/2·~11yr·2 sites in GA

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Inova Health Care Services

Device·Ph 2·~1.5yr·2 sites in VA

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

Exercise in Child Health

University of California, Irvine

~5yr·1 site in CA

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

Indiana University

Device·~5yr·1 site in IN

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Integrative Training Program for Pediatric Sickle Cell Pain

Emory University

Lifestyle·~3yr·4 sites in CT, GA, OH

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

Suvankar Majumdar

Ph 2·~4yr·1 site in DC

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

St. Jude Children's Research Hospital

Ph 1·~3yr·1 site in TN

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Robert Nickel

Ph 2·~13yr·5 sites in DC, IL, NC +2

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

Defibrotide for Sickle Cell Disease Patients Undergoing Stem Cell Transplant

New York Medical College

Ph 2·~11yr·4 sites in CA, FL, NY +1

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD

Enrico Novelli

Procedure·Ph 1·~5yr·1 site in PA

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

Children's National Research Institute

Procedure·Ph 2·~31yr·1 site in DC

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

Sanofi

Ph 3·~12mo·5 sites in GA, NE, NJ +1

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

National Heart, Lung, and Blood Institute (NHLBI)

Ph 1·~17mo·1 site in MD

Enrolling now

14q~4min

Check if I qualify View study

Nationwide

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

Mohsen Saidinejad

Ph 2·~2yr·1 site in CA

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease

Sanofi

Ph 3·~3yr·14 sites in AL, AZ, CA +10

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

Tocilizumab for Acute Chest Syndrome

University of Chicago

Ph 2·~4yr·1 site in IL

Enrolling now

9q~2min

Check if I qualify View study

Nationwide

Cognitive Remediation Intervention to Prepare for Transition of Care

University of Alabama at Birmingham

Lifestyle·Ph 2·~5yr·1 site in AL

Enrolling now

4q~2min

Check if I qualify View study

Nationwide

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

National Heart, Lung, and Blood Institute (NHLBI)

EARLY_Ph 1·~5yr·1 site in MD

Enrolling now

9q~2min

Check if I qualify View study